4SCAR19 Chimeric Antigen Receptor-Modified T Cells As a Breakthrough Therapy for Highly Chemotherapy-Resistant Late-Stage B Cell Lymphoma Patients with Bulky Tumor Mass
暂无分享,去创建一个
Lung-Ji Chang | Jun Zhu | X. Ke | T. Niu | Ting Liu | Yong-qian Jia | H. Jing | Yu-qin Song | Zhuogang Liu | Tong Li | K. Yao | Xiao-pei Wang | Yuchen Liu | Z. Ying | F. Bao | L. Dong | L. Pan | Hao-Hsian Kuo | Yinghong Li